Conditions to Novartis’ Obligations under this Agreement. Novartis’ obligation to complete the transactions contemplated in this Agreement is subject to the fulfillment or waiver of the following conditions: 3.6.1. [***]. From and after the Execution Date and until the Effective Date, there shall have occurred [***]; and 3.6.2. [***]. Akcea shall have duly executed and delivered to Novartis the [***].
Appears in 4 contracts
Samples: Strategic Collaboration, Option and License Agreement (Ionis Pharmaceuticals Inc), Strategic Collaboration, Option and License Agreement (Akcea Therapeutics, Inc.), Strategic Collaboration, Option and License Agreement (Akcea Therapeutics, Inc.)
